Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT07057050
Eligibility Criteria:
Inclusion Criteria:
* The study focuses on patients aged 45-60 years
* Patients who have subacute spastic hemiplegia with occlusion of the middle cerebral artery
* Patients who are able to maintain balance in sitting positions.
* Patients are diagnosed with the affected upper extremity being the dominant side.
* Physiotherapy sessions are initiated 3-7 days post-injection,
* Patients have pre-injection Modified Ashworth scores equal to 2 (moderate spasticity) in wrist or elbow flexors.
* Patients can actively extend joints at least 10° at metacarpophalangeal and interphalangeal joints and 20° at the wrist of the affected upper limb.
Exclusion Criteria:
* Joint immobility in the upper limb due to contracture, bony deformity, or heterotopic ossification
* Significant cognitive deficits (Mini-Mental Status Examination score \<24).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
60 Years
Study:
NCT07057050
Study Brief:
Protocol Section:
NCT07057050